MIRRORS: a prospective cohort study assessing the feasibility of robotic interval debulking surgery for advanced-stage ovarian cancer
Open Access
- 2 June 2024
- journal article
- research article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 34 (6) , 886-897
Abstract
Objective To establish the feasibility and safety of robotic interval debulking surgery following the MIRRORS protocol (robot-assisted laparoscopic assessment prior to robotic or open surgery) in women with advanced-stage ovarian cancer. MIRRORS is the first of three planned trials: MIRRORS, MIRRORS-RCT (pilot), and MIRRORS-RCT. Methods The participants were patients with stage IIIc-IVb epithelial ovarian cancer undergoing neo-adjuvant chemotherapy, suitable for interval debulking surgery with a pelvic mass ≤8 cm. The intervention was robot-assisted laparoscopic assessment prior to robotic or open interval debulking surgery (MIRRORS protocol). The primary outcome was feasibility of recruitment, and the secondary outcomes were quality of life (EORTC QLQC30/OV28, HADS questionnaires), pain, surgical complications, complete cytoreduction rate (%), conversion to open surgery (%), and overall and progression-free survival at 1 year. Results Overall, 95.8% (23/24) of patients who were eligible were recruited. Median age was 68 years (range 53–83). All patients had high grade serous histology and were BRCA negative. In total, 56.5% were stage IV, 43.5% were stage III, 87.0% had a partial response, while 13.0% had stable disease by RECIST 1.1. Median peritoneal cancer index was 24 (range 6–38). Following MIRRORS protocol, 87.0% (20/23) underwent robotic interval debulking surgery, and 13.0% (3/23) had open surgery. All patients achieved RConclusions Robotic interval debulking surgery appears safe and feasible for experienced robotic surgeons in patients with a pelvic mass ≤8 cm. A randomized controlled trial (MIRRORS-RCT) will determine whether MIRRORS protocol has non-inferior survival (overall and progression-free) compared with open interval debulking surgery.Keywords
Funding Information
- GRACE charity
- NIHR Applied Research Collaborations (ARC) Kent Surrey & Sussex (KSS) Greenshoots award
This publication has 27 references indexed in Scilit:
- Minimally invasive interval debulking surgery for advanced ovarian cancer after neoadjuvant chemotherapyGynecologic Oncology, 2023
- Ultra-radical upfront surgery does not improve survival in women with advanced epithelial ovarian cancer; a natural experiment in a complete populationGynecologic Oncology, 2020
- Survival after a nationwide introduction of robotic surgery in women with early-stage endometrial cancer: a population-based prospective cohort studyEuropean Journal of Cancer, 2019
- Interval robotic cytoreduction following neoadjuvant chemotherapy in advanced ovarian cancerJournal of Robotic Surgery, 2017
- British Gynaecological Cancer Society (BGCS) epithelial ovarian/fallopian tube/primary peritoneal cancer guidelines: recommendations for practiceEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2017
- Effect of Total Laparoscopic Hysterectomy vs Total Abdominal Hysterectomy on Disease-Free Survival Among Women With Stage I Endometrial CancerJAMA, 2017
- Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial–NCT02324595): a feasibility studyAmerican Journal of Obstetrics and Gynecology, 2016
- Perioperative and clinical outcomes in the management of epithelial ovarian cancer using a robotic or abdominal approachGynecologic Oncology, 2013
- Risk of postoperative venous thromboembolism after minimally invasive surgery for endometrial and cervical cancer is low: A multi-institutional studyGynecologic Oncology, 2013
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009